Literature DB >> 22995974

ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion.

Richard E Hautmann1, Hassan Abol-Enein, Thomas Davidsson, Sigurdur Gudjonsson, Stefan H Hautmann, Henriette V Holm, Cheryl T Lee, Frederik Liedberg, Stephan Madersbacher, Murugesan Manoharan, Wiking Mansson, Robert D Mills, David F Penson, Eila C Skinner, Raimund Stein, Urs E Studer, Joachim W Thueroff, William H Turner, Bjoern G Volkmer, Abai Xu.   

Abstract

CONTEXT: A summary of the 2nd International Consultation on Bladder Cancer recommendations on the reconstructive options after radical cystectomy (RC), their outcomes, and their complications.
OBJECTIVE: To review the literature regarding indications, surgical details, postoperative care, complications, functional outcomes, as well as quality-of-life measures of patients with different forms of urinary diversion (UD). EVIDENCE ACQUISITION: An English-language literature review of data published between 1970 and 2012 on patients with UD following RC for bladder cancer was undertaken. No randomized controlled studies comparing conduit diversion with neobladder or continent cutaneous diversion have been performed. Consequently, almost all studies used in this report are of level 3 evidence. Therefore, the recommendations given here are grade C only, meaning expert opinion delivered without a formal analysis. EVIDENCE SYNTHESIS: Indications and patient selection criteria have significantly changed over the past 2 decades. Renal function impairment is primarily caused by obstruction. Complications such as stone formation, urine outflow, and obstruction at any level must be recognized early and treated. In patients with orthotopic bladder substitution, daytime and nocturnal continence is achieved in 85-90% and 60-80%, respectively. Continence is inferior in elderly patients with orthotopic reconstruction. Urinary retention remains significant in female patients, ranging from 7% to 50%.
CONCLUSIONS: RC and subsequent UD have been assessed as the most difficult surgical procedure in urology. Significant disparity on how the surgical complications were reported makes it impossible to compare postoperative morbidity results. Complications rates overall following RC and UD are significant, and when strict reporting criteria are incorporated, they are much higher than previously published. Fortunately, most complications are minor (Clavien grade 1 or 2). Complications can occur up to 20 yr after surgery, emphasizing the need for lifelong monitoring. Evidence suggests an association between surgical volume and outcome in RC; the challenge of optimum care for elderly patients with comorbidities is best mastered at high-volume hospitals by high-volume surgeons. Preoperative patient information, patient selection, surgical techniques, and careful postoperative follow-up are the cornerstones to achieve good long-term results.
Copyright © 2012 European Association of Urology. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22995974     DOI: 10.1016/j.eururo.2012.08.050

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  58 in total

1.  Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort.

Authors:  Florian Roghmann; Andreas Becker; Quoc-Dien Trinh; Orchidee Djahangirian; Orchidee Djahagirian; Zhe Tian; Malek Meskawi; Shahrokh F Shariat; Markus Graefen; Pierre Karakiewicz; Joachim Noldus; Maxine Sun
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

2.  Long-term evaluation of modified orthotopic Y-shaped ileal neobladder (Tanta pouch) with left retro-colic chimney.

Authors:  Ayman A Hassan; Mohamed Elbendary; Mohamed Radwan; Mohamed O Abo-Farha; Tarek Gamil; Sherif Salah Azab; Mahmoud S Elmateet
Journal:  Int Urol Nephrol       Date:  2020-01-24       Impact factor: 2.370

Review 3.  Use of Bowel in Reconstructive Urology: What a Colorectal Surgeon Should Know.

Authors:  Christopher D Morrison; Stephanie J Kielb
Journal:  Clin Colon Rectal Surg       Date:  2017-05-22

4.  Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis.

Authors:  Hangchuan Shi; Han Yu; Joaquim Bellmunt; Jeffrey J Leow; Xuanyu Chen; Changcheng Guo; Hongmei Yang; Xiaoping Zhang
Journal:  Qual Life Res       Date:  2018-06-20       Impact factor: 4.147

Review 5.  Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy.

Authors:  Khurram M Siddiqui; Jonathan I Izawa
Journal:  World J Urol       Date:  2015-10-16       Impact factor: 4.226

6.  Unusual late complication following anterior pelvic exenteration and ileal conduit.

Authors:  Rajaraman Ramamurthy; Kavitha Sukumar; Subbiah Shanmugam
Journal:  Indian J Surg Oncol       Date:  2014-10-18

Review 7.  Updates on Robotic Intracorporeal Urinary Diversions.

Authors:  Shawn Dason; Alvin C Goh
Journal:  Curr Urol Rep       Date:  2018-03-15       Impact factor: 3.092

8.  Long-term evaluation of oncologic and functional outcomes after laparoscopic open-assisted radical cystectomy: a matched-pair analysis.

Authors:  Simone Albisinni; Ksenija Limani; Lisa Ingels; Felix Kwizera; Renaud Bollens; Eric Hawaux; Thierry Quackels; Marc Vanden Bossche; Alexandre Peltier; Thierry Roumeguère; Roland van Velthoven
Journal:  World J Urol       Date:  2014-01-28       Impact factor: 4.226

9.  A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer.

Authors:  Sebastian Karl Frees; Jonathan Aning; Peter Black; Werner Struss; Robert Bell; Claudia Chavez-Munoz; Martin Gleave; Alan I So
Journal:  World J Urol       Date:  2017-11-07       Impact factor: 4.226

10.  Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.

Authors:  Wassim Kassouf; Armen Aprikian; Peter Black; Girish Kulkarni; Jonathan Izawa; Libni Eapen; Adrian Fairey; Alan So; Scott North; Ricardo Rendon; Srikala S Sridhar; Tarik Alam; Fadi Brimo; Normand Blais; Chris Booth; Joseph Chin; Peter Chung; Darrel Drachenberg; Yves Fradet; Michael Jewett; Ron Moore; Chris Morash; Bobby Shayegan; Geoffrey Gotto; Neil Fleshner; Fred Saad; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2016-02-08       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.